Synergistic activation of CD4+ T cells by IL-16 and IL-2

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2115-2120

  Parada, Nereida A ^a   Center, David M ^a   Kornfeld, Hardy ^a   Rodriguez, Wilma L ^a   Cook, Jennifer ^a   Vallen, Margaret ^a   Cruikshank, William W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 16; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CROSS LINKING; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DRUG SYNERGISM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-16; INTERLEUKIN-2; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS;

EID: 0032032215     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. + T lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772.
2. + T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143.
3. Mackall, C. L., T. Fleischer, M. Brown, I. Magrath, A. Shad, M. Horowitz, L. Wexler, M. Adder, L. McLure, and R. Gress. 1994. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221.
4. Nemunaitis, J., S. Rabinowe, S. Singer, P. Bierman, J. Vose, and A. Freedman. 1991. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 324:1773.
5. Advani, R., N. J. Chao, S. J. Horning, K. G. Blume, D. K. Ahn, K. R. Lamborn, N. C. Fleming, E. M. Bonnem, and P. L. Greenberg. 1992. Granulocyte-Macrophage colony-stimulating factor (GM-CSF) as an adjuvant to autologous hematopoeitic stem cell transplantation for lymphoma. Ann. Intern. Med. 116:183.
6. Powles, R., C. Smith, S. Milan, J. Treleaven, J. Millar, T. McElwain, E. Gordon-Smith, S. Milliken, and C. Tiley. 1990. Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukemia: double-blind, placebo-controlled trial. Lancet 336:1417.
7. Kovacs, J., M. Baseler, and R. Dewer. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: a preliminary study. N. Engl. J. Med. 332:567.
8. Kovacs, J., S. Vogel, J. Albert, J. Falloon, R. Davey, R. Walker, M. Polis, K. Spooner, J. Metcalf, M. Baseler, G. Fyfe, and C. Lane. 1996. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335:1350.
9. + T cell repertoire that are not immediately restored by anti-viral or immune-based therapies. J. Allergy Clin. Immunol. 99:S110.
10. + T lymphocytes and monocytes. J. Immunol. 138: 3817.
11. Cruikshank, W., D. Center, N. Nisar, M. Wu, B. Natke, A. Theodore, and H. Kornfeld. 1994. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc. Natl. Acad. Sci. USA 91:5109.
12. Cruikshank, W., J. Greenstein, A. Theodore, and D. Center. 1991. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes. J. Immunol. 146:2928.
13. lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J. Biol. Chem. 270:17081.
14. Rand, T. H., W. W. Cruikshank, D. M. Center, and P. F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173: 1521.
15. Parada, N. A., W. W. Cruikshank, H. L. Danis, T. C. Ryan, and D. M. Center. 1996. IL-16 and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 168:100.
16. Cruikshank, W. W., K. Lim, A. C. Theodore, J. Cook, G. Fine, P. F. Weller, and D. M. Center. 1996. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J. Immunol. 157:5240.
17. Theodore, A. C., D. M. Center, J. Nicoll, G. Fine, H. Kornfeld, and W. W. Cruikshank. 1996. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J. Immunol. 157:1958.
18. Ma, A., J. C. Pena, B. Chang, E. Margosian, L. Davidson, F. W. Alt, and C. B. Thompson. 1995. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA 92:4763.
19. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1:197.
20. Tough, D. F., and J. Sprent. 1994. Turnover of naive-and memory-phenotype T cells. J. Exp. Med. 179:1127.
21. + T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry 19:343.
22. Beverely, P. C. L. 1990. Is T-cell memory maintained by crossreactive stimulation? Immunol. Today 11:203.
23. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor γ chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. In Annual Review of Immunology. W. E. Paul, C. G. Fathman, and H. Metzger, eds. Annual Reviews Inc., Palo Alto, p. 179.